Zscaler
ZS
213.55
+1.30
+0.61%
Zscaler
US · ZS
#637 by market cap
Listed 2018
213.55
+1.30
+0.61%
Live - 5344 symbols - heartbeat 505s ago
· 2026-10-08 07:40
Pre-market
213.30
-0.12%
After-hours
214.46
+0.43%
Overnight
213.56
+0.00%
- Market cap
- 34.82B
- P/E (TTM)i
- -547.56
- P/Bi
- 13.40
- EPSi
- -0.39
- Div yieldi
- 0.00%
- 52W posi
- 44%
Reader sentiment
Are you bullish or bearish on ZS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.43, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +25.42% YoY
Margins
- Gross margin
- 76.80%
- Operating margin
- -3.61%
- Net margin
- -1.88%
Key ratios & quality
- Enterprise valuei
- 33.11B
- Altman Z-Scorei
- 4.43
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 302.84M | 431.27M | 673.10M | 1.09B | 1.62B | 2.17B | 2.67B | 3.35B |
| Gross profit | 243.17M | 335.54M | 522.78M | 848.66M | 1.25B | 1.69B | 2.05B | 2.57B |
| Selling & admin expenses | 216.51M | 351.61M | 555.94M | 886.95M | 1.14B | 1.31B | 1.51B | 1.78B |
| Research & development | 61.97M | 97.88M | 174.65M | 289.14M | 350.79M | 499.83M | 672.49M | 903.40M |
| Operating profit | -35.31M | -113.96M | -207.81M | -327.43M | -234.62M | -121.48M | -127.14M | -121.14M |
| Pretax profit | -27.91M | -112.73M | -257.18M | -383.63M | -182.56M | -29.23M | -18.29M | -17.14M |
| Tax | 743.00K | 2.39M | 4.85M | 6.65M | 19.77M | 28.48M | 23.19M | 46.04M |
| Net profit | -28.66M | -115.12M | -262.03M | -390.28M | -202.34M | -57.71M | -41.48M | -63.18M |
| Basic EPS | 0 | -1 | -2 | -3 | -1 | 0 | 0 | 0 |
| Diluted EPS | -0.23 | -0.89 | -1.93 | -2.77 | -1.40 | -0.39 | -0.27 | -0.39 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 678.03M | 719.23M | 788.11M | 815.75M | 850.48M | 898.19M |
| Gross profit | 522.06M | 546.99M | 603.36M | 624.49M | 657.82M | 689.22M |
| Selling & admin expenses | 377.70M | 398.61M | 439.22M | 442.93M | 455.18M | 435.49M |
| Research & development | 169.77M | 177.61M | 200.50M | 229.14M | 232.28M | 241.48M |
| Operating profit | -25.41M | -30.93M | -36.36M | -51.77M | -29.64M | -3.36M |
| Pretax profit | 4.56M | -1.90M | -8.37M | -21.30M | -2.37M | 14.90M |
| Tax | 8.69M | 15.68M | 3.24M | 13.01M | 11.51M | 18.27M |
| Net profit | -4.13M | -17.58M | -11.62M | -34.31M | -13.88M | -3.37M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.03 | -0.11 | -0.07 | -0.21 | -0.09 | -0.02 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 496.09M | 1.58B | 1.85B | 2.26B | 2.89B | 3.40B | 4.89B | 5.03B |
| Cash & ST investments | 364.65M | 1.37B | 1.50B | 1.73B | 2.10B | 2.41B | 3.57B | 3.47B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 604.16M | 1.83B | 2.26B | 2.83B | 3.61B | 4.70B | 6.42B | 7.87B |
| Total current liabilities | 261.95M | 423.90M | 720.21M | 1.13B | 1.54B | 3.11B | 2.43B | 2.96B |
| Short-term debt | -- | 15.60M | 19.84M | 26.10M | 34.47M | 1.19B | 52.50M | 64.89M |
| Long-term debt | -- | 861.62M | 913.54M | 968.67M | 1.13B | -- | 1.70B | 1.70B |
| Total liabilities | 295,604,000.00 | 1,348,629,000.00 | 1,728,736,000.00 | 2,259,365,000.00 | 2,883,205,000.00 | 3,430,866,000.00 | 4,620,615,000.00 | 5,268,453,000.00 |
| Total equity | 308.56M | 484.83M | 528.90M | 573.30M | 725.11M | 1.27B | 1.80B | 2.60B |
| Retained earnings | -224.46M | -339.57M | -601.60M | -991.88M | -1.09B | -1.15B | -1.19B | -1.25B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 3.92B | 4.89B | 4.21B | 4.45B | 4.65B | 5.03B |
| Cash & ST investments | 3.01B | 3.57B | 3.32B | 3.51B | 3.54B | 3.47B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.34B | 6.42B | 6.50B | 6.75B | 7.10B | 7.87B |
| Total current liabilities | 3.17B | 2.43B | 2.31B | 2.34B | 2.50B | 2.96B |
| Short-term debt | 1.20B | 52.50M | 68.40M | 67.59M | 66.75M | 64.89M |
| Long-term debt | -- | 1.70B | 1.70B | 1.70B | 1.70B | 1.70B |
| Total liabilities | 3,534,689,000.00 | 4,620,615,000.00 | 4,520,759,000.00 | 4,557,880,000.00 | 4,731,484,000.00 | 5,268,453,000.00 |
| Total equity | 1.80B | 1.80B | 1.98B | 2.20B | 2.37B | 2.60B |
| Retained earnings | -1.17B | -1.19B | -1.20B | -1.24B | -1.25B | -1.25B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 58.03M | 79.32M | 202.04M | 321.91M | 462.34M | 779.85M | 972.45M | 1.13B |
| Depreciation & amortization | 11.31M | 21.12M | 36.46M | 49.47M | 66.82M | 80.93M | 121.18M | 192.01M |
| Free cash flow | 27.87M | 27.51M | 143.74M | 231.33M | 333.62M | 584.95M | 726.69M | 779.14M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -22.00K | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 78.48M | 141.85M | 275.90M | 1.01B | 1.26B | 1.42B | 2.39B | 928.35M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 211.08M | 250.60M | 448.28M | 204.07M | 198.02M | 279.29M |
| Depreciation & amortization | 32.45M | 34.34M | 41.28M | 46.06M | 49.46M | 55.21M |
| Free cash flow | 119.46M | 171.92M | 413.30M | 169.13M | 135.95M | 60.76M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.99B | 2.39B | 1.34B | 1.20B | 982.11M | 928.35M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -10.44 | -29.02 | -51.70 | -70.82 | -31.17 | -5.77 | -2.70 | -2.87 |
| ROA %i | -5.45 | -9.45 | -12.81 | -15.33 | -6.28 | -1.39 | -0.75 | -0.88 |
| ROIC %i | -10.44 | -8.92 | -15.75 | -22.58 | -13.78 | -6.01 | -4.47 | -3.54 |
| 5-year avg ROE %i | -- | -- | -- | -50.34 | -38.63 | -37.69 | -32.43 | -22.67 |
| EBIT margin %i | -11.66 | -24.97 | -30.67 | -30.23 | -10.89 | -0.74 | -0.49 | -0.40 |
| FCF / sales %i | 9.20 | 6.38 | 21.36 | 21.20 | 20.63 | 26.98 | 27.19 | 23.24 |
| Current ratioi | 1.89 | 3.73 | 2.57 | 1.99 | 1.88 | 1.09 | 2.01 | 1.70 |
| Quick ratioi | 1.75 | 3.58 | 2.44 | 1.88 | 1.75 | 1.01 | 1.88 | 1.56 |
| Debt / assetsi | 0.00 | 49.37 | 42.73 | 36.92 | 33.55 | 26.31 | 27.98 | 23.59 |
| LT debt / equityi | -- | 183.50 | 178.63 | 177.85 | 162.19 | 3.52 | 96.93 | 68.93 |
| Interest coveragei | -- | -21.43 | -4.07 | -6.13 | -26.91 | -1.23 | -2.50 | -3.72 |
| Revenue CAGR (3Y) %i | 55.64 | 50.82 | 52.40 | 53.30 | 55.35 | 47.68 | 34.82 | 27.51 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | 306.69 | 102.48 | 129.75 | 59.65 | 46.46 | 32.67 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -2.68 | -2.70 | -2.41 | -3.56 | -3.71 | -2.87 |
| ROA %i | -0.81 | -0.75 | -0.73 | -1.15 | -1.24 | -0.88 |
| ROIC %i | -4.64 | -4.47 | -4.30 | -4.17 | -4.24 | -3.54 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -0.41 | -0.49 | -0.64 | -0.77 | -0.85 | -0.40 |
| FCF / sales %i | 27.14 | 27.19 | 29.93 | 29.12 | 28.05 | 23.24 |
| Current ratioi | 1.24 | 2.01 | 1.82 | 1.90 | 1.86 | 1.70 |
| Quick ratioi | 1.14 | 1.88 | 1.67 | 1.74 | 1.71 | 1.56 |
| Debt / assetsi | 23.01 | 27.98 | 28.20 | 27.60 | 26.22 | 23.59 |
| LT debt / equityi | 1.81 | 96.93 | 89.07 | 81.82 | 75.82 | 68.93 |
| Interest coveragei | -0.94 | -2.50 | -4.28 | -5.79 | -3.97 | -3.72 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
United States53.45%
Europe, Middle East and Africa27.54%
Asia Pacific15.49%
Other3.52%
Quote time 2026-10-08 07:40:10 · For reference only, not investment advice and not tailored to your situation.